Anebulo is a startup based in the United States.
Anebulo Pharmaceuticals develops Selonabant, a drug candidate aimed at reversing acute cannabis-induced toxicities, particularly in children, addressing serious conditions like CNS and respiratory depression caused by unintentional cannabis exposure.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.